Literature DB >> 11890873

Methotrexate shows marginal clinical efficiency in early scleroderma.

John Varga1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11890873     DOI： 10.1007/s11926-002-0003-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  6 in total

1.  Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

Authors:  J R Seibold; J H Korn; R Simms; P J Clements; L W Moreland; M D Mayes; D E Furst; N Rothfield; V Steen; M Weisman; D Collier; F M Wigley; P A Merkel; M E Csuka; V Hsu; S Rocco; M Erikson; J Hannigan; W S Harkonen; M E Sanders
Journal:  Ann Intern Med       Date:  2000-06-06       Impact factor: 25.391

2.  Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

Authors:  F H van den Hoogen; A M Boerbooms; A J Swaak; J J Rasker; H J van Lier; L B van de Putte
Journal:  Br J Rheumatol       Date:  1996-04

3.  High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.

Authors:  P J Clements; D E Furst; W K Wong; M Mayes; B White; F Wigley; M H Weisman; W Barr; L W Moreland; T A Medsger; V Steen; R W Martin; D Collier; A Weinstein; E Lally; J Varga; S Weiner; B Andrews; M Abeles; J R Seibold
Journal:  Arthritis Rheum       Date:  1999-06

4.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

Authors:  A H Rook; B Freundlich; B V Jegasothy; M I Perez; W G Barr; S A Jimenez; R L Rietschel; B Wintroub; M B Kahaleh; J Varga
Journal:  Arch Dermatol       Date:  1992-03

5.  Low-dose methotrexate in the treatment of widespread morphea.

Authors:  M M Seyger; F H van den Hoogen; T de Boo; E M de Jong
Journal:  J Am Acad Dermatol       Date:  1998-08       Impact factor: 11.527

6.  Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients.

Authors:  P J Clements; P A Lachenbruch; M Sterz; G Danovitch; R Hawkins; A Ippoliti; H E Paulus
Journal:  Arthritis Rheum       Date:  1993-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.